Quick Answer
IONIS PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 163.30 million shares for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed an increase of +3.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), IONIS PHARMACEUTICALS INC's Common Stock Shares Outstanding has grown by 65.2%.
- Historical annual values: Fiscal year 2025: 163.30 million shares | Fiscal year 2024: 157.91 million shares | Fiscal year 2023: 144.34 million shares | Fiscal year 2022: 142.06 million shares | Fiscal year 2021: 141.21 million shares | Fiscal year 2020: 140.37 million shares | Fiscal year 2019: 140.34 million shares | Fiscal year 2018: 137.93 million shares | Fiscal year 2017: 124.98 million shares | Fiscal year 2016: 121.64 million shares | Fiscal year 2015: 120.35 million shares | Fiscal year 2014: 118.44 million shares | Fiscal year 2013: 116.47 million shares | Fiscal year 2012: 101.48 million shares | Fiscal year 2011: 100.04 million shares | Fiscal year 2010: 99.39 million shares | Fiscal year 2009: 98.85 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: